As JIB-04 treatment reduced MECOM expression in ovarian cells harboring MECOM amplification, we aimed to explore the tumor inhibitory activity of JIB-04 towards ovarian cancer cells harboring MECOM amplification, and efficacy studies were performed in SKOV3 cell-derived ovarian tumor mice model. This evidence concerns the gene MECOM and neoplasm.